Megan Othus1, Aasthaa Bansal2, Harry Erba3, Scott Ramsey4. 1. Fred Hutchinson Cancer Research Center, Seattle, WA, USA; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA. Electronic address: mothus@fredhutch.org. 2. The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA. 3. Duke University, Durham, NC, USA. 4. Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Abstract
OBJECTIVES: When populations contain mixtures of cured and uncured patients, the use of traditional parametric approaches to estimate overall survival (OS) can be biased. Mixture cure models may reduce bias compared with traditional parametric models, but their accuracy is subject to certain conditions. Importantly, mixture cure models assume that that there is enough follow-up to identify individuals censored at the end of the follow-up period as cured. The purpose of this article is to describe biases that can occur when mixture cure models are used to estimate mean survival from data with limited follow-up. METHODS: We analyzed 6 trials conducted by the SWOG Cancer Research Network Leukemia Committee. For each trial, we analyzed 2 data sets: the data released to the committee when the results of the trial were unblinded and a second data set with additional follow-up. We estimated mean OS using parametric survival models with and without a cure fraction. RESULTS: When using mixture cure models, in 4 trials, estimates of mean OS were higher with the first analysis (with limited follow-up) compared with estimates from data with longer follow-up. In 1 trial, the reverse pattern was observed. In 1 trial, the cure estimate changed little with additional follow-up. CONCLUSIONS: Caution should be taken when using mixture cure models in scenarios with limited follow-up. The biases resulting from fitting these models may be exacerbated when the models are being used to extrapolate OS and estimate mean OS.
OBJECTIVES: When populations contain mixtures of cured and uncured patients, the use of traditional parametric approaches to estimate overall survival (OS) can be biased. Mixture cure models may reduce bias compared with traditional parametric models, but their accuracy is subject to certain conditions. Importantly, mixture cure models assume that that there is enough follow-up to identify individuals censored at the end of the follow-up period as cured. The purpose of this article is to describe biases that can occur when mixture cure models are used to estimate mean survival from data with limited follow-up. METHODS: We analyzed 6 trials conducted by the SWOG Cancer Research Network Leukemia Committee. For each trial, we analyzed 2 data sets: the data released to the committee when the results of the trial were unblinded and a second data set with additional follow-up. We estimated mean OS using parametric survival models with and without a cure fraction. RESULTS: When using mixture cure models, in 4 trials, estimates of mean OS were higher with the first analysis (with limited follow-up) compared with estimates from data with longer follow-up. In 1 trial, the reverse pattern was observed. In 1 trial, the cure estimate changed little with additional follow-up. CONCLUSIONS: Caution should be taken when using mixture cure models in scenarios with limited follow-up. The biases resulting from fitting these models may be exacerbated when the models are being used to extrapolate OS and estimate mean OS.
Authors: F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba Journal: N Engl J Med Date: 2010-06-05 Impact factor: 91.245
Authors: Joshua A Roth; Sean D Sullivan; Vincent W Lin; Aasthaa Bansal; Anna G Purdum; Lynn Navale; Paul Cheng; Scott D Ramsey Journal: J Med Econ Date: 2018-10-16 Impact factor: 2.448
Authors: Aasthaa Bansal; Sean D Sullivan; Vincent W Lin; Anna G Purdum; Lynn Navale; Paul Cheng; Scott D Ramsey Journal: Med Decis Making Date: 2019-02-28 Impact factor: 2.583
Authors: Sucha Nand; Megan Othus; John E Godwin; Cheryl L Willman; Thomas H Norwood; Dianna S Howard; Steven E Coutre; Harry P Erba; Frederick R Appelbaum Journal: Blood Date: 2013-10-03 Impact factor: 22.113
Authors: Stephen H Petersdorf; Kenneth J Kopecky; Marilyn Slovak; Cheryl Willman; Thomas Nevill; Joseph Brandwein; Richard A Larson; Harry P Erba; Patrick J Stiff; Robert K Stuart; Roland B Walter; Martin S Tallman; Leif Stenke; Frederick R Appelbaum Journal: Blood Date: 2013-04-16 Impact factor: 22.113
Authors: Jerald P Radich; Kenneth J Kopecky; Frederick R Appelbaum; Suzanne Kamel-Reid; Wendy Stock; Greg Malnassy; Elisabeth Paietta; Martha Wadleigh; Richard A Larson; Peter Emanuel; Martin Tallman; Jeff Lipton; A Robert Turner; Michael Deininger; Brian J Druker Journal: Blood Date: 2012-08-22 Impact factor: 22.113
Authors: Mikkael A Sekeres; Megan Othus; Alan F List; Olatoyosi Odenike; Richard M Stone; Steven D Gore; Mark R Litzow; Rena Buckstein; Min Fang; Diane Roulston; Clara D Bloomfield; Anna Moseley; Aziz Nazha; Yanming Zhang; Mario R Velasco; Rakesh Gaur; Ehab Atallah; Eyal C Attar; Elina K Cook; Alyssa H Cull; Michael J Rauh; Frederick R Appelbaum; Harry P Erba Journal: J Clin Oncol Date: 2017-05-09 Impact factor: 50.717
Authors: Melanie D Whittington; R Brett McQueen; Daniel A Ollendorf; Varun M Kumar; Richard H Chapman; Jeffrey A Tice; Steven D Pearson; Jonathan D Campbell Journal: JAMA Netw Open Date: 2019-02-01
Authors: Christopher Jackson; John Stevens; Shijie Ren; Nick Latimer; Laura Bojke; Andrea Manca; Linda Sharples Journal: Med Decis Making Date: 2016-07-10 Impact factor: 2.583
Authors: Han Fu; Deedra Nicolet; Krzysztof Mrózek; Richard M Stone; Ann-Kathrin Eisfeld; John C Byrd; Kellie J Archer Journal: Stat Med Date: 2022-07-06 Impact factor: 2.497